Articles by W Ruzyllo (3)

Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial

B. E Claessen, M. A Beijk, V Legrand, W Ruzyllo, A Manari, O Varenne, M. J Suttorp, J. G.P Tijssen, K Miquel Hebert, S Veldhof, J. P.S Henriques, P. W Serruys and J. J. Piek

Circulation: Cardiovascular Interventions 2 ( 4 ): 339 - 347 , 2009

Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial

B. E Claessen, M. A Beijk, V Legrand, W Ruzyllo, A Manari, O Varenne, M. J Suttorp, J. G.P Tijssen, K Miquel Hebert, S Veldhof, J. P.S Henriques, P. W Serruys and J. J. Piek

Circulation: Cardiovascular Interventions 2 ( 4 ): 339 - 347 , 2009

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

M Tendera, W Wojakowski, W Ruzyllo, L Chojnowska, C Kepka, W Tracz, P Musialek, W Piwowarska, J Nessler, P Buszman, S Grajek, P Breborowicz, M Majka, M. Z Ratajczak and for the REGENT Investigators (REGENT investigators are listed in the Appendix)

European Heart Journal 30 ( 11 ): 1313 - 1321 , 2009